To the editor,

The article by Ren et al. reported that there was an extremely high incidence (85.4%) of lower extremity deep venous thrombosis (DVT) among 48 patients with severe coronavirus disease 2019 (COVID-19) in Wuhan, China \[[@CR1]\]. As the global pandemic of COVID-19, there have been several studies on the incidence, risk factors, and preventive strategies of DVT \[[@CR1]--[@CR4]\]. However, the incidence of DVT has been reported diversely among different clinical centers. Thus, we performed a meta-analysis to estimate the pooled prevalence of DVT in confirmed COVID-19 patients.

We searched PubMed, EMBASE, Web of Science, and medRxiv databases until June 22, 2020, for relevant studies, using the keywords ("coronavirus" or "COVID-19" or "SARS-CoV-2" or "2019-nCoV") and ("thrombosis" or "thrombi" or "thrombus"). In addition, we screened out the relevant potential articles in the references of selected studies. Articles reporting the prevalence of DVT in confirmed COVID-19 patients were included.

The pooled prevalence and its 95% confidence interval (CI) were used to estimate the combined effects. We calculated the prevalence estimates with the variance stabilizing double arcsine transformation \[[@CR5], [@CR6]\]. The heterogeneity among studies was assessed with the *I*^2^ statistic and Cochran's *Q* test. The meta-regression and subgroup analysis were used to investigate the potential heterogeneity sources (such as sample size, prevalence of prophylaxis in COVID-19 patients, location, design of studies, screening methods of DVT, and COVID-19 patients in intensive care unit (ICU)). We chose Egger's test and Begg's test to assess publication bias. All analyses were performed using the Stata 11.2 (StataCorp, College Station, TX), and a two-tailed *P* value \< 0.05 was considered to be statistically significant.

A total of 1202 records were initially identified by our searches. We finally included 28 articles in our meta-analysis. The basic characteristics of included studies are shown in Table [1](#Tab1){ref-type="table"}. There were 397 DVT cases in a total of 4138 COVID-19 patients. The pooled estimate of the prevalence for DVT was 16% by using a random-effects model (95% CI 10--23%, *P* \< 0.01, *I*^2^ = 96.81, *Q* = 846.41, *P* \< 0.01) (Fig. [1](#Fig1){ref-type="fig"}a). According to patients' geographic location, the much higher pooled prevalence of DVT was found in COVID-19 patients from China (30%, 95% CI 2--72%, *P* = 0.02, *I*^2^ = 98.73%, *Q* = 313.90, *P* \< 0.01) compared with those from western countries (13%, 95% CI 8--19%, *P* \< 0.01, *I*^2^ = 95.62%, *Q* = 502.07, *P* \< 0.01) (Fig. [1](#Fig1){ref-type="fig"}b). Twenty articles clearly reported the prevalence of DVT in COVID-19 patients treated in ICU or non-ICU. The pooled prevalence of DVT in COVID-19 patients treated in ICU was 23% (95% CI 11--38%, *P* \< 0.01, *I*^2^ = 96.44%, *Q* = 421.29, *P* \< 0.01), which was significantly higher than in COVID-19 patients treated in non-ICU (5%, 95% CI 1--11%, *P* \< 0.01, *I*^2^ = 92.17%, *Q* = 89.42, *P* \< 0.01) (Fig. [1](#Fig1){ref-type="fig"}c, d). We found significant publication bias by Egger's test (*P* \< 0.001) and Begg's test (*P* \< 0.001). The subgroup analysis showed that none of these factors could explain the significant heterogeneity. However, the meta-regression analysis of multiple covariates indicated that the geographic location of patients could partially explain heterogeneity (*P* = 0.036). Table 1Characteristics of the included studiesAuthorsSampleAgeMale (%)LocationDesign of studiesScreening of DVTICU/non-ICU\*Prophylaxis (%)DVT (%)Zhang et al. (PMID: 32421381)14363 (mean)74 (51.7)ChinaCross-sectional studyUltrasoundN/R53 (37.1)66 (46.2)Ren et al. (PMID: 32412320)4870 (median)26 (54.2)ChinaCross-sectional studyUltrasoundICU47 (97.9)41 (85.4)Demelo-Rodríguez et al. (PMID: 32405101)15668.1 (mean)102 (65.4)SpainProspective studyUltrasoundNon-ICU153 (98.1)23 (14.7)Middeldorp et al. (PMID: 32369666)19861 (mean)130 (65.7)NetherlandsRetrospective studyUltrasoundICU/non-ICU198 (100)26 (13.1)Bi et al.^†^42045 (mean)200 (47.6)ChinaProspective studyN/RN/RN/R6 (1.4)Klok et al. (PMID: 32291094)18464 (mean)139 (75.5)NetherlandsProspective studyUltrasoundICU184 (100)1 (0.5)Karmen-Tuohy et al.^‡^6361 (mean)57 (90.5)USAProspective studyN/RN/RN/R2 (3.2)Llitjos et al. (PMID: 32320517)2668 (median)20 (76.9)FranceRetrospective studyUltrasoundICU8 (30.8)14 (53.8)Lodigiani et al. (PMID: 32353746)38866 (median)264 (68.0)ItalyRetrospective studyUltrasoundICU/non-ICU307 (79.1)6 (1.7)^§^Helms et al. (PMID: 32367170)15063 (median)122 (81.3)FranceProspective studyImagingICU150 (100)3 (2.0)Stoneham et al. (PMID: 32423903)274N/RN/RUKProspective studyImagingN/RN/R5 (1.8)Galeano-Valle et al. (PMID: 32425261)785N/RN/RSpainProspective studyUltrasoundNon-ICU780 (99.4)13 (1.7)Xing et al. (PMID: 32345353)20N/R12 (60.0)ChinaRetrospective studyUltrasoundN/RN/R7 (35.0)Beyls et al. (PMID: 32414510)1262 (median)10 (83.3)FranceRetrospective studyUltrasoundN/RN/R6 (50.0)Poissy et al. (PMID: 32330083)107N/RN/RFranceRetrospective studyUltrasoundICU107 (100)5 (4.7)Beun et al. (PMID: 32311843)75N/RN/RNetherlandsRetrospective studyN/RICUN/R3 (4.0)Cattaneo et al. (PMID: 32349132)6470 (median)35 (54.7)ItalyRetrospective studyUltrasoundNon-ICU64 (100)0 (0.0)Tavazzi et al. (PMID: 32322918)54N/RN/RItalyRetrospective studyUltrasoundICU54 (100)8 (14.8)Voicu et al. (PMID: 32479784)56N/R42 (75.0)FranceProspective studyUltrasoundICU49 (87.5)26 (46.4)Hippensteel et al. (PMID: 32484907)9156.5 (mean)53 (58.2)USARetrospective studyUltrasoundICUN/R11 (12.1)Fraissé et al. (PMID: 32487122)9261 (median)73 (79.3)FranceRetrospective studyN/RICU92 (100)6 (6.5)Desborough et al. (PMID: 32485437)6659 (median)48 (72.7)UKRetrospective studyImagingICU66 (100)6 (9.1)Al-Samkari et al. (PMID: 32492712)40061.8 (mean)228 (57.0)USARetrospective studyImagingN/R400 (100)10 (2.5)Edler et al. (PMID: 32500199)8079.2 (mean)46 (57.5)GermanyProspective studyN/RN/RN/R32 (40.0)Grandmaison et al. (PMID: 32529170)58N/RN/RSwitzerlandCross-sectional studyUltrasoundICU/non-ICUN/R28 (48.3)Artifoni et al. (PMID: 32451823)7164 (median)43 (60.6)FranceRetrospective studyUltrasoundNon-ICU70 (98.6)15 (21.1)Nahum et al. (PMID: 32469410)3462.2 (mean)25 (73.5)FranceProspective studyUltrasoundICU34 (100)27 (79.4)Zhang et al. (PMID: 32553905)2344.7 (mean)15 (65.2)ChinaProspective studyN/RICU/non-ICUN/R1 (4.3)*DVT* deep vein thrombosis, *ICU* intensive care unit, *N/R* not (clearly) reported\*Articles clearly reported the prevalence of DVT in COVID-19 patients treated in ICU or non-ICU^†^doi: 10.1101/2020.04.22.20076190^‡^doi: 10.1101/2020.05.07.20094797^§^Data missing for patientsFig. 1Forest plots of pooled prevalence and its 95% confidence interval (CI) for deep vein thrombosis (DVT) in confirmed coronavirus disease 2019 (COVID-19) patients (**a**) and subgroup analysis by patients' geographic location (**b**) and the severity of disease (**c**, **d**)

In conclusion, more attention should be paid to the prevention and clinical management of DVT, especially for COVID-19 patients in ICU, and timely assessment of DVT is essential. However, there was considerable heterogeneity in our meta-analysis. In addition, there was significant publication bias in our meta-analysis, although we searched four databases as many and as carefully as possible. Finally, we included non-survival patients who were seriously ill and may exaggerate the prevalence of DVT in COVID-19 patients.
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